Key facts
- This page summarizes Timothy C. Fiori's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 29 Jan 2026, 11:43.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Option grant made to Mr. Fiori in connection with his employment as Chief Financial Officer. The option shall be treated as an incentive stock option to the maximum extent permitted by the International Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 40,000 options on the first, second and third anniversary of the grant date.